Mizuho Medy Co.,Ltd. (TYO:4595)
Japan · Delayed Price · Currency is JPY 1,679.00
+4.00 (0.24%)
Jun 22, 2026, 1:54 PM JST
Mizuho Medy Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,819 | 11,260 | 11,429 | 10,989 | 17,581 | 13,137 | |
Revenue Growth (YoY) | -4.56% | -1.48% | 4.00% | -37.49% | 33.83% | 212.41% |
Cost of Revenue | 3,394 | 3,441 | 3,345 | 2,915 | 3,482 | 3,485 |
Gross Profit | 7,425 | 7,819 | 8,084 | 8,074 | 14,099 | 9,652 |
Selling, General & Admin | 2,281 | 2,311 | 2,338 | 2,205 | 2,337 | 2,316 |
Research & Development | 819 | 819 | 783 | 669 | 605 | 592 |
Operating Expenses | 3,142 | 3,172 | 3,166 | 2,922 | 2,995 | 2,953 |
Operating Income | 4,283 | 4,647 | 4,918 | 5,152 | 11,104 | 6,699 |
Interest Expense | - | - | - | - | - | -1 |
Interest & Investment Income | 105 | 100 | 75 | 41 | 9 | 1 |
Currency Exchange Gain (Loss) | 99 | -13 | 167 | 91 | -50 | - |
Other Non Operating Income (Expenses) | 7 | 5 | 6 | 8 | 7 | - |
EBT Excluding Unusual Items | 4,494 | 4,739 | 5,166 | 5,292 | 11,070 | 6,699 |
Gain (Loss) on Sale of Investments | - | -4 | - | - | - | - |
Other Unusual Items | - | - | - | - | - | 124 |
Pretax Income | 4,494 | 4,735 | 5,166 | 5,292 | 11,070 | 6,823 |
Income Tax Expense | 1,245 | 1,310 | 1,393 | 1,518 | 3,232 | 2,007 |
Net Income | 3,249 | 3,425 | 3,773 | 3,774 | 7,838 | 4,816 |
Net Income to Common | 3,249 | 3,425 | 3,773 | 3,774 | 7,838 | 4,816 |
Net Income Growth | -9.25% | -9.22% | -0.03% | -51.85% | 62.75% | 1473.86% |
Shares Outstanding (Basic) | 19 | 19 | 19 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 19 | 19 | 19 | 10 | 10 | 10 |
Shares Change (YoY) | -11.11% | - | 100.00% | - | - | -0.00% |
EPS (Basic) | 170.56 | 179.80 | 198.07 | 396.24 | 822.93 | 505.64 |
EPS (Diluted) | 170.56 | 179.80 | 198.07 | 396.24 | 822.93 | 505.64 |
EPS Growth | 2.10% | -9.22% | -50.01% | -51.85% | 62.75% | 1473.87% |
Free Cash Flow | - | 1,701 | 3,049 | 3,728 | 5,993 | 5,442 |
Free Cash Flow Per Share | - | 89.30 | 160.06 | 391.41 | 629.22 | 571.37 |
Gross Margin | 68.63% | 69.44% | 70.73% | 73.47% | 80.20% | 73.47% |
Operating Margin | 39.59% | 41.27% | 43.03% | 46.88% | 63.16% | 50.99% |
Profit Margin | 30.03% | 30.42% | 33.01% | 34.34% | 44.58% | 36.66% |
Free Cash Flow Margin | - | 15.11% | 26.68% | 33.92% | 34.09% | 41.42% |
EBITDA | 4,559 | 4,913 | 5,146 | 5,347 | 11,290 | 6,871 |
EBITDA Margin | 42.13% | 43.63% | 45.03% | 48.66% | 64.22% | 52.30% |
D&A For EBITDA | 275.5 | 266 | 228 | 195 | 186 | 172 |
EBIT | 4,283 | 4,647 | 4,918 | 5,152 | 11,104 | 6,699 |
EBIT Margin | 39.59% | 41.27% | 43.03% | 46.88% | 63.16% | 50.99% |
Effective Tax Rate | 27.70% | 27.67% | 26.96% | 28.68% | 29.20% | 29.42% |
Advertising Expenses | - | - | - | - | - | 224 |